Homoeopathy in Vitiligo

Comparative Effectiveness of Individualized Homoeopathic Medicine and Hydrocotyle asiatica in the treatment of Vitiligo in Paediatric age group – an Open-label, Randomised, Clinical trial - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/03/063945

Enrollment

Registered

2024-03-11

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L80- Vitiligo

Interventions

Intervention1: Individualized Homoeopathic Medicine: It is planned as administering indicated homoeopathic medicines in optimum potency, as decided appropriate to the case or condition, dosage and rep

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosed with vitiligo on the basis of clinical features. Patients of all religions and socioeconomic conditions and have not taken any treatment in the last 4 weeks for vitiligo. Patient willing to give informed consent and assent as required.

Exclusion criteria

Exclusion criteria: 1. Patients or parents of the patient unwilling to give consent. 2. Cases with substance abuse or any psychiatric illness. 3. Congenital anomaly, critically ill and immune-compromised patients. 4. Children suffering from uncontrolled systemic diseases.

Design outcomes

Primary

Measure	Time frame
Vitiligo Area Scoring Index (VASI)Timepoint: Basline and after 6th month	—

Secondary

Measure	Time frame
Children’s Dermatological Life Quality Index (CDLQI)Timepoint: Basline and after 6th month	—

Countries

India

Contacts

Public ContactDr Shishir Kumar Singh

National Institute of Homoeopathy

drshishirsinghmd@gmail.com7890321978

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026